PMID: 11912942Mar 27, 2002Paper

Designer drugs in the general hospital

The Psychiatric Clinics of North America
Philip A Bialer

Abstract

This article has reviewed the potential complications of acute intoxication and withdrawal from some of the more commonly used club, or designer, drugs. Although limited, acute use of these drugs is claimed by users to be benign, in the context of crowded raves and circuit parties, where multiple drugs may be used, hyperthermia, dehydration, and life-threatening reactions may occur. In addition, mounting evidence of the long-term effects of continued use of these drugs is cause for great concern. Finally, awareness of a severe withdrawal syndrome from GHB and its precursors is particularly important to psychiatrists of the medically ill, who may be called on to help in the management of these patients.

References

Nov 30, 1990·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control (CDC)
Apr 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·U D McCannG A Ricaurte
Jan 1, 1994·Lancet·G P GallowayF Staggers
Jun 1, 1996·The American Journal of Psychiatry·H T BabergJ E Dimsdale
May 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A K MalhotraA Breier
Apr 1, 1996·Journal of Psychoactive Drugs·P J Dalgarno, D Shewan
Aug 1, 1996·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·U D McCannG A Ricaurte
Nov 1, 1996·Neurology·E J Carrazana
Aug 1, 1997·The American Journal of Psychiatry·L Misra, L Kofoed
Nov 21, 1997·The American Journal of Drug and Alcohol Abuse·V R SanguinetiM R Frank
Mar 14, 1998·Psychopharmacology·J H KrystalD S Charney
Mar 26, 1998·The American Journal of Drug and Alcohol Abuse·M HernandezO J Hernandez
Jun 6, 1998·The Journal of the American Board of Family Practice·B Hodges, J Everett
Jun 13, 1998·Annals of Emergency Medicine·R L ChinT D Wu
Jun 13, 1998·Annals of Emergency Medicine·J LiA Woeckener
Aug 14, 1998·The American Journal on Addictions·R N RosenthalC R Miner
Aug 14, 1998·The American Journal on Addictions·K P Pages, R K Ries
Oct 9, 1998·Journal of Hepatology·V AndreuJ Rodés
Dec 16, 1998·Lancet·J A Henry, I R Hill
Dec 17, 1998·Neurology·K I BollaG A Ricaurte
Apr 8, 1999·Anaesthesia·P C Kam, F F Yoong
Apr 29, 1999·The Journal of the American Board of Family Practice·J A Rochester, J T Kirchner
Apr 30, 1999·Journal of Psychopharmacology·P K Gillman
Jun 4, 1999·Journal of Pain and Symptom Management·M C EnarsonM A Woodroffe
Jan 11, 2000·The British Journal of Psychiatry : the Journal of Mental Science·J ObrockiT Schiemann
Jan 25, 2000·The Journal of Emergency Medicine·K CraigT C Bania
May 16, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·P A Kelly
Jun 1, 2000·Journal of Clinical Psychopharmacology·L K MisraG A Richards
Jun 23, 2000·The Journal of Emergency Medicine·M IngelsR F Clark
Apr 1, 1997·Journal of Clinical Psychopharmacology·A P Popli
Sep 30, 2000·General Hospital Psychiatry·J S MiglaniR Chahil
Jan 11, 2001·The New England Journal of Medicine·D L ZvosecE A Peacock

❮ Previous
Next ❯

Citations

Mar 2, 2005·Journal of Urban Health : Bulletin of the New York Academy of Medicine·M Isabel FernándezG Stephen Bowen
Jun 14, 2005·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Richard Yeatman
Jul 29, 2005·Substance Use & Misuse·Gena Covell Britt, Elinore F McCance-Katz
Oct 1, 2011·Drug Testing and Analysis·Laurent Karila, Michel Reynaud
Feb 18, 2006·Drug and Alcohol Dependence·Li-Tzy WuDeborah M Galvin
Sep 10, 2009·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Florian D ZepfLars Wöckel
Oct 21, 2015·Medizinische Klinik, Intensivmedizin und Notfallmedizin·F Erbguth
Mar 17, 2004·Current Opinion in Pediatrics·Lindara L Halloran, David W Bernard
Jul 29, 2005·Substance Use & Misuse·Jane Carlisle Maxwell
Jul 29, 2005·Substance Use & Misuse·Jane Carlisle Maxwell, Richard T Spence

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Substance Abuse
A M MattisonSan Diego HIV Neurobehavioral Research Center Group
Drug and Alcohol Dependence
K L Nicholson, R L Balster
Journal of Substance Abuse Treatment
Thomas E FreeseC J Reback
© 2022 Meta ULC. All rights reserved